Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Biologics Offers In-House Formulation Development
Breaking News

Cytovance Biologics Expands Services with In-House Formulation Development

This expansion provides an integrated one-stop shop approach for existing and future clients.

Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), has launched in-house formulation development services, reinforcing the company’s position as a full-service partner for biologic drug developers.

This expansion reflects Cytovance’s continued investment in innovation and commitment to delivering comprehensive solutions for complex development challenges. The new services are available to support existing and future client programs. 

“Our formulation development workflow is grounded in Quality by Design (QbD) principles to deliver speed, safety, and data-driven precision from the outset,” said Fuad Haddadin, Head of R&D at Cytovance Biologics. “Bringing formulation expertise in-house not only strengthens our technical capabilities but also reinforces our mission to deliver smarter, faster, and more reliable development paths for our clients.”

Axel Schleyer, Chief Commercial Officer of Cytovance Biologics, added, “It allows us to better serve our clients by accelerating development timelines and providing a truly integrated one-stop-shop approach, all while maintaining the highest standards of quality and regulatory compliance.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters